📰 Pediatric Immunotherapy Program News
Pediatric Immunotherapy Program News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Pediatric Immunotherapy Program. Real-time updates on events, politics, business and more.
April 27, 2023
Augusta (Georgia), April 25: Children with recurrent brain tumours tolerated the first in-human trial of a novel immunotherapy well, and many were able to experience unexpected months of a more normal life, according to researchers. Immunotherapy disables a natural enzyme that tumours hijack for their defence.
April 25, 2023
The first in-human-study of a new immunotherapy that blocks a natural enzyme tumors commandeer for their protection was well tolerated by children with relapsed brain tumors and enabled many to have unexpected months of a more normal life, researchers say.
April 25, 2023
The first in-human-study of a new immunotherapy that blocks a natural enzyme tumors commandeer for their protection was well tolerated by children with relapsed brain tumors and enabled many to have unexpected months of a more normal life, researchers say.
April 25, 2023
Children with recurrent brain tumours tolerated the first in-human trial of a novel immunotherapy well, and many were able to experience unexpected months of a more normal life, according to researchers
November 17, 2022
The conversations between our bone and muscle change as we age, and both are the weaker for it, Medical College of Georgia scientists say.